Changeflow GovPing Insurance OR Insurance Bulletins
Favicon for dfr.oregon.gov

OR Insurance Bulletins

RSS

Thursday, March 19, 2026

Favicon for dfr.oregon.gov

Oregon Bulletin: Relief for Federal Shutdown Victims

The Oregon Division of Financial Regulation issued a bulletin encouraging state-regulated financial institutions to provide relief to individuals affected by the federal government shutdown. The guidance suggests accommodations such as waiving fees, deferring payments, and suspending collection activities for affected residents.

Priority review Guidance Consumer Finance
Favicon for dfr.oregon.gov

Oregon Insurance Bulletin: Relief for Federal Shutdown

The Oregon Division of Financial Regulation issued Bulletin DFR 2025-8 encouraging insurance companies to provide relief to policyholders affected by the federal government shutdown. The bulletin suggests measures such as grace periods for payments and waiving late fees for affected individuals.

Priority review Guidance Insurance
Favicon for dfr.oregon.gov

Oregon Investment Advisers: Fees for Availability Guidance

The Oregon Division of Financial Regulation issued guidance clarifying that state investment advisers may not charge fees solely for availability. Such fees, regardless of their label, are considered unreasonable and a breach of fiduciary duty if not commensurate with rendered advisory services.

Priority review Guidance Financial Services
Favicon for dfr.oregon.gov

Affordable Housing Insurance Export List Guidance

The Oregon Department of Consumer and Business Services issued guidance on January 21, 2026, establishing an export list for affordable housing commercial property and liability insurance. This allows surplus lines carriers to provide coverage without a prior diligent search of the admitted market, as mandated by SB 829 (2025).

Priority review Guidance Insurance
Favicon for dfr.oregon.gov

Oregon Drug Price Increase Reporting Guidance Withdrawn

The Oregon Department of Consumer and Business Services has withdrawn guidance related to drug price increase reports. This action reinstates the requirement for prescription drug manufacturers to file annual price increase reports, following a court ruling that overturned a previous suspension.

Priority review Notice Healthcare

Get OR Insurance Bulletins alerts

We'll email you when OR Insurance Bulletins publishes new changes.

Free. Unsubscribe anytime.